FRAZER, Pa., May 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) announced that John E. Osborn, Executive Vice President and General
Counsel, has been nominated by President George W. Bush to serve as a
member of the United States Advisory Commission on Public Diplomacy. The
Commission is a seven member bipartisan panel established by the Congress
in 1948 to provide advice and oversight of all U.S. Government activities
intended to understand, inform, and influence foreign publics. The
nomination is subject to confirmation by the United States Senate. The
White House announcement concerning the nomination can be found at
http://www.whitehouse.gov/news/releases/2007/05/20070510-11.html .
Osborn will continue to manage all legal, government and public affairs
matters for Cephalon.
From 1989 to 1992, Osborn served as Special Assistant to the Legal
Adviser with the U.S. Department of State during the George H.W. Bush
Administration, and prior to that worked in the offices of former U.S.
Representative Jim Leach of Iowa and the late U.S. Senator John Heinz of
Pennsylvania. Osborn also worked on several presidential campaigns,
beginning with the 1980 Bush campaign. In 2004, Osborn was appointed by
then U.S. Secretary of State Colin L. Powell to serve as one of five
national members of the Board of Governors of the East-West Center, an
education and research organization based in Honolulu, Hawaii that is
focused on the Asia Pacific region.
Osborn has held a visiting appointment in politics at Princeton
University, where he was a research fellow at the University's Bobst Center
for Peace and Justice, and has been an Eisenhower Fellow to Ireland and
Northern Ireland, and a visiting scholar in East European Studies with the
Woodrow Wilson International Center for Scholars in Washington. He is a
member of the Council on Foreign Relations and the American Law Institute,
and a fellow of the American Bar Foundation.
The U.S. Advisory Commission on Public Diplomacy
The Commission, now in its 59th year, was reauthorized in May 2007
pursuant to Public Law 110-21. It is responsible for assessing public
diplomacy policies and programs of the U.S. State Department, American
missions abroad, and other agencies. Advisory Commission responsibilities
extend to international exchanges, U.S. Government international
information programs, and publicly funded non-governmental organizations.
The Commission reports its findings and recommendations to the President,
the Congress, the Secretary of State, and the American people. For more on
the Commission, please visit http://www.state.gov/r/adcompd .
Cephalon, Inc.
Founded in 1987, Cephalon, Inc. is an international biopharmaceutical
company dedicated to the discovery, development and marketing of innovative
products in four core therapeutic areas: central nervous system, pain,
oncology and addiction. A first time member of the Fortune 1000, Cephalon
currently employs approximately 3,000 people in the United States and
Europe. U.S. sites include the company's headquarters in Frazer,
Pennsylvania, and offices, laboratories or manufacturing facilities in West
Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis,
Minnesota. Cephalon's European headquarters are located in Maisons-Alfort,
France. The company's proprietary products in the United States include:
PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet)
[C-II], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone
for extended-release injectable suspension), GABITRIL(R) (tiagabine
hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II].
The Company also markets numerous products internationally. Full
prescribing information on its U.S. products is available at
http://www.cephalon.com or by calling 1-800-896-5855.
SOURCE Cephalon, Inc.
 back to top
Related links:
http://www.cephalon.com
http://www.state.gov/r/adcompd
http://www.prnewswire.com/comp/134563.html /
CONTACT:
Sheryl Williams of Cephalon, Inc.,
+1-610-738-6493, swilliam@cephalon.com
|
